The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Gel Fiber Hemostatic Patch Market Research Report 2024

Global Gel Fiber Hemostatic Patch Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1739920

No of Pages : 106

Ask Your Query

Synopsis
Gel fiber hemostatic patch is a kind of medical dressing, which is usually used to control traumatic bleeding. It is made of cellulose or other fibrous materials, usually in the form of a bandage or patch. These dressings contain components that can promote coagulation, such as coagulation factors and fibrinogen. When the dressing comes into contact with the wound, these components will interact with platelets and plasma proteins in the blood to form clots and stop bleeding. The gel fiber hemostatic patch is usually used to stop bleeding after surgery and trauma, and can also be used to control other types of bleeding.

Global Gel Fiber Hemostatic Patch market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gel Fiber Hemostatic Patch market research.

Key manufacturers engaged in the Gel Fiber Hemostatic Patch industry include Johnson & Johnson, Baxter International, Pfizer, Medtronic, Abbott Laboratories, Becton, Dickinson and Company, Stryker Corporation, Olympus Corporation and Terumo Corporation, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Gel Fiber Hemostatic Patch were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Gel Fiber Hemostatic Patch market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gel Fiber Hemostatic Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Johnson & Johnson
  • Baxter International
  • Pfizer
  • Medtronic
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Stryker Corporation
  • Olympus Corporation
  • Terumo Corporation
  • Teleflex Incorporated
  • Integra LifeSciences
  • Boston Scientific Corporation
  • Cook Medical
  • Smith & Nephew
  • Zimmer Biomet
  • Cardinal Health
  • Edwards Lifesciences

Segment by Type

  • Oxidized Regenerated Cellulose Patch
  • Chitosan Patch
  • Collagen Patch

Segment by Application

  • Hospital
  • Clinic

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Gel Fiber Hemostatic Patch report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Gel Fiber Hemostatic Patch Market Overview
1.1 Product Overview and Scope of Gel Fiber Hemostatic Patch
1.2 Gel Fiber Hemostatic Patch Segment by Type
1.2.1 Global Gel Fiber Hemostatic Patch Market Value Comparison by Type (2023-2029)
1.2.2 Oxidized Regenerated Cellulose Patch
1.2.3 Chitosan Patch
1.2.4 Collagen Patch
1.3 Gel Fiber Hemostatic Patch Segment by Application
1.3.1 Global Gel Fiber Hemostatic Patch Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Gel Fiber Hemostatic Patch Market Size Estimates and Forecasts
1.4.1 Global Gel Fiber Hemostatic Patch Revenue 2018-2029
1.4.2 Global Gel Fiber Hemostatic Patch Sales 2018-2029
1.4.3 Global Gel Fiber Hemostatic Patch Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Gel Fiber Hemostatic Patch Market Competition by Manufacturers
2.1 Global Gel Fiber Hemostatic Patch Sales Market Share by Manufacturers (2018-2023)
2.2 Global Gel Fiber Hemostatic Patch Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Gel Fiber Hemostatic Patch Average Price by Manufacturers (2018-2023)
2.4 Global Gel Fiber Hemostatic Patch Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Gel Fiber Hemostatic Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gel Fiber Hemostatic Patch, Product Type & Application
2.7 Gel Fiber Hemostatic Patch Market Competitive Situation and Trends
2.7.1 Gel Fiber Hemostatic Patch Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gel Fiber Hemostatic Patch Players Market Share by Revenue
2.7.3 Global Gel Fiber Hemostatic Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gel Fiber Hemostatic Patch Retrospective Market Scenario by Region
3.1 Global Gel Fiber Hemostatic Patch Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gel Fiber Hemostatic Patch Global Gel Fiber Hemostatic Patch Sales by Region: 2018-2029
3.2.1 Global Gel Fiber Hemostatic Patch Sales by Region: 2018-2023
3.2.2 Global Gel Fiber Hemostatic Patch Sales by Region: 2024-2029
3.3 Global Gel Fiber Hemostatic Patch Global Gel Fiber Hemostatic Patch Revenue by Region: 2018-2029
3.3.1 Global Gel Fiber Hemostatic Patch Revenue by Region: 2018-2023
3.3.2 Global Gel Fiber Hemostatic Patch Revenue by Region: 2024-2029
3.4 North America Gel Fiber Hemostatic Patch Market Facts & Figures by Country
3.4.1 North America Gel Fiber Hemostatic Patch Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gel Fiber Hemostatic Patch Sales by Country (2018-2029)
3.4.3 North America Gel Fiber Hemostatic Patch Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gel Fiber Hemostatic Patch Market Facts & Figures by Country
3.5.1 Europe Gel Fiber Hemostatic Patch Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gel Fiber Hemostatic Patch Sales by Country (2018-2029)
3.5.3 Europe Gel Fiber Hemostatic Patch Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gel Fiber Hemostatic Patch Market Facts & Figures by Country
3.6.1 Asia Pacific Gel Fiber Hemostatic Patch Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gel Fiber Hemostatic Patch Sales by Country (2018-2029)
3.6.3 Asia Pacific Gel Fiber Hemostatic Patch Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gel Fiber Hemostatic Patch Market Facts & Figures by Country
3.7.1 Latin America Gel Fiber Hemostatic Patch Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gel Fiber Hemostatic Patch Sales by Country (2018-2029)
3.7.3 Latin America Gel Fiber Hemostatic Patch Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Gel Fiber Hemostatic Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Gel Fiber Hemostatic Patch Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gel Fiber Hemostatic Patch Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gel Fiber Hemostatic Patch Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gel Fiber Hemostatic Patch Sales by Type (2018-2029)
4.1.1 Global Gel Fiber Hemostatic Patch Sales by Type (2018-2023)
4.1.2 Global Gel Fiber Hemostatic Patch Sales by Type (2024-2029)
4.1.3 Global Gel Fiber Hemostatic Patch Sales Market Share by Type (2018-2029)
4.2 Global Gel Fiber Hemostatic Patch Revenue by Type (2018-2029)
4.2.1 Global Gel Fiber Hemostatic Patch Revenue by Type (2018-2023)
4.2.2 Global Gel Fiber Hemostatic Patch Revenue by Type (2024-2029)
4.2.3 Global Gel Fiber Hemostatic Patch Revenue Market Share by Type (2018-2029)
4.3 Global Gel Fiber Hemostatic Patch Price by Type (2018-2029)
5 Segment by Application
5.1 Global Gel Fiber Hemostatic Patch Sales by Application (2018-2029)
5.1.1 Global Gel Fiber Hemostatic Patch Sales by Application (2018-2023)
5.1.2 Global Gel Fiber Hemostatic Patch Sales by Application (2024-2029)
5.1.3 Global Gel Fiber Hemostatic Patch Sales Market Share by Application (2018-2029)
5.2 Global Gel Fiber Hemostatic Patch Revenue by Application (2018-2029)
5.2.1 Global Gel Fiber Hemostatic Patch Revenue by Application (2018-2023)
5.2.2 Global Gel Fiber Hemostatic Patch Revenue by Application (2024-2029)
5.2.3 Global Gel Fiber Hemostatic Patch Revenue Market Share by Application (2018-2029)
5.3 Global Gel Fiber Hemostatic Patch Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Johnson & Johnson Gel Fiber Hemostatic Patch Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Baxter International
6.2.1 Baxter International Corporation Information
6.2.2 Baxter International Description and Business Overview
6.2.3 Baxter International Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Baxter International Gel Fiber Hemostatic Patch Product Portfolio
6.2.5 Baxter International Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Gel Fiber Hemostatic Patch Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Corporation Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Medtronic Gel Fiber Hemostatic Patch Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 Abbott Laboratories
6.5.1 Abbott Laboratories Corporation Information
6.5.2 Abbott Laboratories Description and Business Overview
6.5.3 Abbott Laboratories Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Abbott Laboratories Gel Fiber Hemostatic Patch Product Portfolio
6.5.5 Abbott Laboratories Recent Developments/Updates
6.6 Becton, Dickinson and Company
6.6.1 Becton, Dickinson and Company Corporation Information
6.6.2 Becton, Dickinson and Company Description and Business Overview
6.6.3 Becton, Dickinson and Company Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Becton, Dickinson and Company Gel Fiber Hemostatic Patch Product Portfolio
6.6.5 Becton, Dickinson and Company Recent Developments/Updates
6.7 Stryker Corporation
6.6.1 Stryker Corporation Corporation Information
6.6.2 Stryker Corporation Description and Business Overview
6.6.3 Stryker Corporation Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Stryker Corporation Gel Fiber Hemostatic Patch Product Portfolio
6.7.5 Stryker Corporation Recent Developments/Updates
6.8 Olympus Corporation
6.8.1 Olympus Corporation Corporation Information
6.8.2 Olympus Corporation Description and Business Overview
6.8.3 Olympus Corporation Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Olympus Corporation Gel Fiber Hemostatic Patch Product Portfolio
6.8.5 Olympus Corporation Recent Developments/Updates
6.9 Terumo Corporation
6.9.1 Terumo Corporation Corporation Information
6.9.2 Terumo Corporation Description and Business Overview
6.9.3 Terumo Corporation Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Terumo Corporation Gel Fiber Hemostatic Patch Product Portfolio
6.9.5 Terumo Corporation Recent Developments/Updates
6.10 Teleflex Incorporated
6.10.1 Teleflex Incorporated Corporation Information
6.10.2 Teleflex Incorporated Description and Business Overview
6.10.3 Teleflex Incorporated Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Teleflex Incorporated Gel Fiber Hemostatic Patch Product Portfolio
6.10.5 Teleflex Incorporated Recent Developments/Updates
6.11 Integra LifeSciences
6.11.1 Integra LifeSciences Corporation Information
6.11.2 Integra LifeSciences Gel Fiber Hemostatic Patch Description and Business Overview
6.11.3 Integra LifeSciences Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Integra LifeSciences Gel Fiber Hemostatic Patch Product Portfolio
6.11.5 Integra LifeSciences Recent Developments/Updates
6.12 Boston Scientific Corporation
6.12.1 Boston Scientific Corporation Corporation Information
6.12.2 Boston Scientific Corporation Gel Fiber Hemostatic Patch Description and Business Overview
6.12.3 Boston Scientific Corporation Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Boston Scientific Corporation Gel Fiber Hemostatic Patch Product Portfolio
6.12.5 Boston Scientific Corporation Recent Developments/Updates
6.13 Cook Medical
6.13.1 Cook Medical Corporation Information
6.13.2 Cook Medical Gel Fiber Hemostatic Patch Description and Business Overview
6.13.3 Cook Medical Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Cook Medical Gel Fiber Hemostatic Patch Product Portfolio
6.13.5 Cook Medical Recent Developments/Updates
6.14 Smith & Nephew
6.14.1 Smith & Nephew Corporation Information
6.14.2 Smith & Nephew Gel Fiber Hemostatic Patch Description and Business Overview
6.14.3 Smith & Nephew Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Smith & Nephew Gel Fiber Hemostatic Patch Product Portfolio
6.14.5 Smith & Nephew Recent Developments/Updates
6.15 Zimmer Biomet
6.15.1 Zimmer Biomet Corporation Information
6.15.2 Zimmer Biomet Gel Fiber Hemostatic Patch Description and Business Overview
6.15.3 Zimmer Biomet Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Zimmer Biomet Gel Fiber Hemostatic Patch Product Portfolio
6.15.5 Zimmer Biomet Recent Developments/Updates
6.16 Cardinal Health
6.16.1 Cardinal Health Corporation Information
6.16.2 Cardinal Health Gel Fiber Hemostatic Patch Description and Business Overview
6.16.3 Cardinal Health Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Cardinal Health Gel Fiber Hemostatic Patch Product Portfolio
6.16.5 Cardinal Health Recent Developments/Updates
6.17 Edwards Lifesciences
6.17.1 Edwards Lifesciences Corporation Information
6.17.2 Edwards Lifesciences Gel Fiber Hemostatic Patch Description and Business Overview
6.17.3 Edwards Lifesciences Gel Fiber Hemostatic Patch Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Edwards Lifesciences Gel Fiber Hemostatic Patch Product Portfolio
6.17.5 Edwards Lifesciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gel Fiber Hemostatic Patch Industry Chain Analysis
7.2 Gel Fiber Hemostatic Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gel Fiber Hemostatic Patch Production Mode & Process
7.4 Gel Fiber Hemostatic Patch Sales and Marketing
7.4.1 Gel Fiber Hemostatic Patch Sales Channels
7.4.2 Gel Fiber Hemostatic Patch Distributors
7.5 Gel Fiber Hemostatic Patch Customers
8 Gel Fiber Hemostatic Patch Market Dynamics
8.1 Gel Fiber Hemostatic Patch Industry Trends
8.2 Gel Fiber Hemostatic Patch Market Drivers
8.3 Gel Fiber Hemostatic Patch Market Challenges
8.4 Gel Fiber Hemostatic Patch Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock